Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors

Go back to Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors
(NASDAQ: DNTH) Delayed: 113.70 --0 (-0%)
Previous Close $113.70    52 Week High
Open $113.70    52 Week Low
Day High $113.70    P/E N/A 
Day Low $113.70    EPS
Volume 221